Cicero, A.F.G.; Fogacci, F.; Derosa, G.; D’Angelo, A.; Ventura, F.; Rizzoli, E.; D’Addato, S.; Borghi, C.; on behalf of the Brisighella Heart Study Group.
Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study. Biomedicines 2022, 10, 656.
https://doi.org/10.3390/biomedicines10030656
AMA Style
Cicero AFG, Fogacci F, Derosa G, D’Angelo A, Ventura F, Rizzoli E, D’Addato S, Borghi C, on behalf of the Brisighella Heart Study Group.
Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study. Biomedicines. 2022; 10(3):656.
https://doi.org/10.3390/biomedicines10030656
Chicago/Turabian Style
Cicero, Arrigo F. G., Federica Fogacci, Giuseppe Derosa, Angela D’Angelo, Fulvio Ventura, Elisabetta Rizzoli, Sergio D’Addato, Claudio Borghi, and on behalf of the Brisighella Heart Study Group.
2022. "Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study" Biomedicines 10, no. 3: 656.
https://doi.org/10.3390/biomedicines10030656
APA Style
Cicero, A. F. G., Fogacci, F., Derosa, G., D’Angelo, A., Ventura, F., Rizzoli, E., D’Addato, S., Borghi, C., & on behalf of the Brisighella Heart Study Group.
(2022). Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study. Biomedicines, 10(3), 656.
https://doi.org/10.3390/biomedicines10030656
